Breaking News: IoVance Biotherapeutics Shares Exciting Corporate, Clinical, and Regulatory Updates!

Acquisition of Worldwide Rights to Proleukin® Provides Immediate and Ongoing Revenue and Secures IL-2 Supply for Clinical and Future Commercial TIL Therapy Positive FDA Feedback on Phase 3 Confirmatory Study in Frontline Advanced (Metastatic or Unresectable) Melanoma Positive Clinical Data in Anti-PD-1 Naïve Metastatic Non-Small Cell Lung Cancer (NSCLC) Biologics License Application (BLA) Submission in…

Read More

Collaboration and Support: Barnwell Industries Inc. Reaches Agreement with Largest Stockholders

Barnwell Industries, Inc. Reaches Cooperation and Support Agreement With its Largest Stockholders Agrees to Reconstitute Its Board and Extend Standstill Agreement HONOLULU, Jan. 23, 2023 (GLOBE NEWSWIRE) — Barnwell Industries, Inc. (NYSE-American: BRN) (“Barnwell” or the “Company”) announced today that it has entered into a cooperation and support agreement (the “Agreement”) with its two largest…

Read More

Attention Shareholders: Pomerantz Law Firm Issues Reminder for Bioventus Inc. Investors Facing Losses – Don’t Miss the Upcoming Class Action Lawsuit Deadline!

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bioventus Inc. of Class Action Lawsuit New York, Jan. 21, 2023 (GLOBE NEWSWIRE) Pomerantz LLP announces that a class action lawsuit has been filed against Bioventus Inc. (“Bioventus” or the “Company”) (NASDAQ: BVS) and certain officers and directors. The class action, filed…

Read More

Get Ready to Invest: PIMCO Global Income Opportunities Fund and PIMCO Tactical Income Fund Launch at the Market Equity Program!

Welcome to the World of At-The-Market Equity Programs! Introduction Today, we are diving into the exciting world of at-the-market equity programs with PIMCO Global Income Opportunities Fund (PGI) and PIMCO Tactical Income Fund (PTI) leading the charge. These programs are designed to provide the Funds with flexibility and efficiency when it comes to raising capital…

Read More